跳至主要内容
临床试验/CTRI/2017/04/008386
CTRI/2017/04/008386
已完成
3 期

Evaluation of efficacy and safety of â??AHPL/AYTOP/2014Aâ?? in patients suffering from aphthous ulcers - an open label, randomized, multi-center, prospective, active controlled, parallel group, clinical study. - NI

Ari Healthcare Pvt Ltd0 个研究点目标入组 0 人待定

概览

阶段
3 期
干预措施
未指定
疾病 / 适应症
未指定
发起方
Ari Healthcare Pvt Ltd
状态
已完成
最后更新
4年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
待定
结束日期
待定
最后更新
4年前
研究类型
Interventional

研究者

发起方
Ari Healthcare Pvt Ltd

入排标准

入选标准

  • 1\.Patients clinically diagnosed as aphthous ulcers
  • 2\.Minor Mouth ulcers that have appeared less than a week prior to the enrollment
  • 3\.Ulcers at accessible locations (labial, buccal mucosa, tongue preferably)
  • 4\.Who can make all necessary visits and comply with the study procedures
  • 5\.Subject willing to participate in clinical trial and who have read, understood and signed informed consent form

排除标准

  • 1\.Subjects Suffering from any other oral or dental disease or active skin disease.
  • 2\.Patient under treatment of ulcers with systemic steroids, vitamins, antibiotics, antihistamines, oral Retinoids or immunomodulatory agents within three months before study entry.
  • 3\.Patients having any major systemic diseases including genetic, endocrinal diseases, cancer, HIV, AIDS
  • 4\.Known cases of hematological disorders, ulcerative colitis or Crohns disease.
  • 5\.Patient who had a history of probable sensitivity to any mouthwash or toothpaste
  • 6\.Patients having Anemia or known iron, folic acid, Vit. B12 deficiency
  • 7\.Patient having addiction of alcohol or smoking or tobacco chewing
  • 8\.Pregnant or lactating women
  • 9\.Patients having known hypersensitivity to ingredients used in the study drugs

结局指标

主要结局

未指定

相似试验